Trade ARTV anytime, even after market hours
Regulated by
MAS
Trusted by
400,000+ users
Artiva Biotherapeutics, Inc. (ARTV) is trading at US$11.09, down 7.12% today as of Aug 28, 16:00 EDT. The company has a market capitalisation of US$534.37M. Over the past 52 weeks, ARTV has traded between US$2.22 and US$14.53. On Syfe you can trade ARTV with $0 commission and add it to your watchlist.
| Previous close | US$11.94 |
|---|---|
| Market cap | US$534.37M |
| 52-week range | US$2.22 – US$14.53 |
| Volume | 222.79K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Artiva Biotherapeutics, Inc.
Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.
Year: 2024
Artiva Biotherapeutics Reports Positive AlloNK Data Across Autoimmune Diseases at EULAR 2026
Jun 8, 11:17 AM · MT Newswires
Artiva Biotherapeutics Appoints Diego Miralles as President
May 19, 12:57 PM · MT Newswires
Sector Update: Healthcare Stocks Steady Pre-Bell Friday
May 8, 1:16 PM · MT Newswires
Wedbush Adjusts Price Target on Artiva Biotherapeutics to $40 From $23, Maintains Outperform Rating
May 8, 12:28 PM · MT Newswires
Top Premarket Gainers
May 8, 11:31 AM · MT Newswires
Artiva Biotherapeutics, Inc. (ARTV) stock is trading at US$11.09, -7.12% from the previous close of US$11.94.
The market cap for Artiva Biotherapeutics, Inc. (ARTV) stock is approximately US$534.37M.
The 52-week high for Artiva Biotherapeutics, Inc. (ARTV) stock is US$14.53.
The 52-week low for Artiva Biotherapeutics, Inc. (ARTV) stock is US$2.22.
Artiva Biotherapeutics, Inc. (ARTV) does not currently pay a dividend.
Stay on top of ARTV
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
